Gilead Sciences, Inc. (GILD) Misses Q4 EPS by 8c, Sales Top Slightly
Tweet
Share
E-mailGet Alerts GILD Hot Sheet
Price: $130.80 +0.75%
Revenue Growth %: +4.2%
Financial Fact:
Net income: 3.33B
Today's EPS Names:
CCEL, MHGU, PLG, More
Revenue Growth %: +4.2%
Financial Fact:
Net income: 3.33B
Today's EPS Names:
CCEL, MHGU, PLG, More
Join SI Premium – FREE
Gilead Sciences, Inc. (NASDAQ: GILD) reported Q4 EPS of $0.97, $0.08 worse than the analyst estimate of $1.05. Revenue for the quarter came in at $2.2 billion versus the consensus estimate of $2.18 billion.
For earnings history and earnings-related data on Gilead Sciences, Inc. (GILD) click here.
For earnings history and earnings-related data on Gilead Sciences, Inc. (GILD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Jefferies upgrades Shopify to Buy on AI commerce tailwinds, sees 30% upside
- Landstar System (LSTR) PT Raised to $186 at Stifel
- BofA turns bearish on Papa John’s, sees limited upside amid fierce competition
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
